Abstract
We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improvement of patient flow in the emergency department toward inpatient wards.
Keywords: COVID-19; Hologic Panther Point of care device; ID NOW; SARS-CoV-2.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2., ID NOW, Hologic Panther Point of care device, 【초록키워드】 SARS-CoV-2, infection control, emergency department, Measures, implementation, Patient, Care, Device, positive, facilitate, faster, Point, 【제목키워드】 SARS-CoV-2, Retrospective study, nasopharyngeal, molecular,
【저자키워드】 COVID-19, SARS-CoV-2., ID NOW, Hologic Panther Point of care device, 【초록키워드】 SARS-CoV-2, infection control, emergency department, Measures, implementation, Patient, Care, Device, positive, facilitate, faster, Point, 【제목키워드】 SARS-CoV-2, Retrospective study, nasopharyngeal, molecular,
{{{ 추상적인 }}}
SARS-COV-2 검출을 위해 ID Now™와 Hologic® Panther Aptima™를 비교했습니다. ID Now™는 각각 86.9%와 99.7%의 긍정 및 부정 비율 동의를 보였습니다. 이를 통해 감염 관리 조치의 신속한 구현과 함께 보다 빠른 임상 의사 결정을 용이하게 하고 응급실에서 입원 병동으로 환자 흐름을 개선할 수 있습니다.
{{ 키워드: }} 코로나19; Hologic Panther 현장 진료 장치; 아이디 나우; 사스 코로나바이러스 2.